Chemical industry – Page 92
-
Business
Judge reverses jury decision over $6.5m Takeda payout
Not enough evidence to link diabetes drug to bladder cancer, the company claims
-
Business
Appeal reverses ECHA call for animal tests
Automotive refrigerant will not need further toxicity studies under the Reach regulation
-
Business
Bayer buys Conceptus for $1.1bn
Deal gives German pharma giant access to surgery-free permanent birth control procedure
-
Business
Portable detector shines light on fake drugs
Testing for counterfeit antimalarials in Africa will help validate a new tool for inspectors
-
Business
US sues Novartis over alleged kickbacks
Company fraudulently paid pharmacies to switch patients onto its drugs, government claims
-
BusinessIreland picks preferred drugs
Using the cheapest of equivalent options could save healthcare providers millions
-
Business
1050 jobs shed in Sabic restructuring
Cuts will be spread across European operations, but the Netherlands and UK take the brunt
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
BusinessThermo Fisher to buy Life Technologies in $15.8bn deal
Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
-
BusinessDeadly blast destroys US fertiliser plant
Up to 15 dead and over 160 injured in a fire and explosion in Waco, Texas
-
Business
Waitrose bans neonicotinoid pesticides
Supermarket introduces precautionary ban on fresh produce suppliers using neonicotinoids until their effect on bees is clarified
-
Business
BASF introduces cell-based allergen test
Non-animal test for cosmetic ingredients to comply with Reach regulation
-
Business
Veolia and Total open oil recycling plant
Osilub plant will re-refine used oils into high grade engine lubricants
-
Business
DuPont and Monsanto settle Roundup dispute
Firms drop expensive ongoing litigation in favour of a licensing deal
-
FeatureFrom molecules to medicines
Turning an active drug molecule into a finished product requires as much chemistry as developing the drug in the first place, as Phillip Broadwith discovers
-
Business
Morning sickness drug reintroduced to US
After being withdrawn due to litigation, the drug has been approved by the FDA
-
Business
European project to boost industry energy efficiency
Initiative will focus on smaller companies and provide tools to assess and reduce energy use
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted
-
Business
Amylin headquarters to close with further job losses
Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger